Rheopheresis

DEVICE2 trials

Sponsors

OccuLogix, Association ECHO

Conditions

Age-Related MaculopathyCalcifying Uremic ArteriolopathyRheopheresisUremic Calciphylaxis

Phase 3

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

SuspendedNCT00460967

OccuLogixAge-Related Maculopathy

Start: 2007-01-31End: 2009-12-31Target: 325Updated: 2007-11-07

Unknown Phase

Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)

CompletedNCT05633121

Association ECHOCalcifying Uremic Arteriolopathy, Rheopheresis, Uremic Calciphylaxis

Start: 2021-05-20End: 2023-09-30Updated: 2023-12-07